High Blood Pressure Treatment (cont.)
John P. Cunha, DO, FACOEP
John P. Cunha, DO, FACOEP
John P. Cunha, DO, is a U.S. board-certified Emergency Medicine Physician. Dr. Cunha's educational background includes a BS in Biology from Rutgers, the State University of New Jersey, and a DO from the Kansas City University of Medicine and Biosciences in Kansas City, MO. He completed residency training in Emergency Medicine at Newark Beth Israel Medical Center in Newark, New Jersey.
In this Article
Calcium channel blockers (CCBs)
Calcium channel blockers inhibit the movement of calcium into the muscle cells of the heart and arteries. Calcium is needed for these muscles to contract. Calcium channel blockers lower blood pressure by decreasing the force of the heart's pumping action and relaxing the muscle cells in the walls of the arteries.
Three major types of calcium channel blockers are used. One type is the dihydropyridines, which do not slow the heart rate or cause other abnormal heart rates or rhythms (cardiac arrhythmias). These drugs include amlodipine (Norvasc), sustained release nifedipine (Procardia XL, Adalat CC), felodipine (Plendil), and nisoldipine (Sular).
The other two types of calcium channel blockers are referred to as the non-dihydropyridine agents. One type is verapamil (Calan, Covera, Isoptin, and Verelan) and the other is diltiazem (Cardizem, Tiazac, Dilacor, and Diltia). The non-dihydropyridines can cause slowing of the heart rate (bradycardia). The non-dihydropyridines are not recommended in congestive heart failure. Both the dihydropyridines and the non-dihydropyridines are very useful when used alone or in combination with other antihypertensive agents.
Many of the calcium channel blockers come in a short-acting form and a long-acting (sustained release) form. The short-acting forms of the calcium channel blockers may have adverse long-term consequences, such as strokes or heart attacks. These effects are due to the wide fluctuations in the blood pressure and heart rate that occur during treatment resulting from the rapid onset and short duration of the short-acting compounds. When the calcium channel blockers are used in sustained release preparations less fluctuation occurs. The sustained release forms of calcium channel blockers are probably safer for long-term use. The main side effects of these drugs include constipation, swelling (edema), and a slow heart rate (only with the non-dihydropyridine types).
Medically Reviewed by a Doctor on 10/11/2012
Viewers share their comments
High Blood Pressure Treatment - Experience Question: What kinds of treatments have been effective for your high blood pressure?
High Blood Pressure Treatment - Diet Question: How did you change your diet to lower your blood pressure?
High Blood Pressure Treatment - Smoking Question: Are you a smoker or former smoker undergoing treatment for high blood pressure? After diagnosis, did you quit smoking?
High Blood Pressure Treatment - Alcohol Question: Do you have hypertension and also drink alcohol? Have you cut back since receiving a diagnosis?
High Blood Pressure Treatment - Coffee and Caffeine Question: In what ways do coffee and other caffeinated beverages affect your blood pressure?
High Blood Pressure Treatment - Medications Question: What medications and other types of treatment do you receive for hypertension?
High Blood Pressure Treatment - Alternative Medicine Question: Describe any alternative or complementary medicine you use to treat your high blood pressure.